PRESS DIGEST - Wall Street Journal - Feb 23
Feb 23 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Jan 5 Ocera Therapeutics Inc :
* Ocera Therapeutics Inc - announces successful phase 1 clinical study of orally-administered ocr-002 in patients with cirrhosis
* Ocera Therapeutics Inc - company plans to initiate phase 2a in h1 2017 with new optimized tablet formulation
* Ocera Therapeutics Inc- ocr-002 was observed to be safe and well-tolerated across all treatment arms in study
* Ocera Therapeutics Inc - ocr-002 demonstrated absolute oral bioavailability of greater than 95 pct in fasted state Source text for Eikon: Further company coverage:
Feb 23 Britain's FTSE 100 index is seen opening 4 points higher, or up 0.05 percent on Thursday, according to Financial spreadbetters. * The blue-chip FTSE 100 index ended up 0.4 percent at 7302.25 points, as Lloyds reported its highest annual profit in a decade and Unilever promised a far-reaching review. * BANK OF ENGLAND: Bank of England Deputy Governor Jon Cunliffe warned on Wednesday that requiring financial instruments to be cleared in a country that uses the c
LONDON, Feb 23 Britain's BAE Systems said it expected increased defence budgets to boost its earnings by 5-10 percent this year after it met market expectations with a 7 percent rise in 2016.